• Matthew J Bottomley and Paul N Harden.
• Churchill Hospital, Roosevelt Drive, Oxford, UK.
• Br. Med. Bull. 2013 Jan 1; 106: 117-34.

IntroductionPowerful immunosuppressive regimens have reduced rejection risk, leading to an expanding cohort of long-term kidney transplant recipients who are likely to encounter practitioners in other specialties.Sources Of DataKey review papers and primary literature identified through searches of PubMed, Google Scholar and Medline.Areas Of AgreementDeath from cardiovascular disease and malignancy remain the chief causes of transplant loss. Risk factors and phenotypes for these differ from the general population.Areas Of ControversyMany guidelines for renal transplant recipients are based on extrapolation from studies on non-transplant cohorts and may not be appropriate. Emerging studies demonstrate that established interventions in the general population are less efficacious in transplant recipients.Growing PointsThe influence of immunosuppression on the development of complications.Areas Timely For Developing ResearchMarkers to guide individualized optimal immunosuppression and predict the development of complications would allow for targeted early intervention.

24 keywords...

hide…